Geistlich Sons Ltd are the UK affiliate for Geistlich Pharma AG, who produce and distribute medical devices and drugs (anti-infectives, vitamins) for regenerative medicine at the Wolhusen and Root sites in central Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its three business units Geistlich Biomaterials, Geistlich Surgery and Geistlich Medical have nine subsidiaries and global distribution. Some 450 employees work for the company around the world. The company is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials.
Geistlich Biomaterials are the worldwide experts in regenerative dentistry. Some 1,000 pre-clinical and clinical studies prove the success in practice of Geistlich Bio-Oss® and Geistlich Bio-Gide®. For 30 years, Geistlich Biomaterials has been the undisputed No. 1 in regenerative dentistry. The excellent results of guided bone regeneration with Geistlich Bio-Oss® and Geistlich Bio-Gide®, are largely due to their unsurpassed biofunctionality. The products are perfectly suited to combined use: Geistlich Bio-Oss® forming the scaffold for the in-growing blood vessels and bone-forming osteoblasts. Whilst Geistlich Bio-Gide® provides an optimal barrier, shielding the young bone from the surrounding connective tissue cells and supporting wound healing. Geistlich Bio-Oss® Collagen and the Geistlich Bio-Oss® Pen provide superior handling options, further enhancing the range from the worldwide No.1 supplier of biomaterials.
Company’s Keywords:
regenerative dentistry, medical devices, bone & soft tissue, collagen expertise
<9
<
<1960